Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 481 of 5804
-
New Clot-Busting device could offer quick relief for lung blockages
Disease control Recruiting nowThis study is a prospective, single-arm, interventional, multicenter study to evaluate the safety and effectiveness of percutaneous mechanical thrombectomy using the Akura Thrombectomy System in subjects with acute pulmonary embolism (PE).
Phase: NA • Sponsor: Akura Medical • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New blood filter could save lives in septic shock
Disease control ENROLLING_BY_INVITATIONThere is a lack of evidence in the efficacy of extracorporeal blood purification (EBP) to reduce the mortality rate in septic shock. We have designed the EABPSS (Efficacy of Adaptive Blood Purification for Septic Shock) study to confirm whether adaptive blood purification (ABP) i…
Phase: NA • Sponsor: Beijing Chao Yang Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Heart radiation: a new hope for failing hearts?
Disease control Recruiting nowPreliminary data suggests that patients suffering from advanced refractory heart failure (HF) could benefit from single low dose whole heart external beam radiotherapy (EBRT). Objective: To explore in our center the efficacy of administering a EBRT treatment of 5Gy to the whole …
Phase: NA • Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New antibiotic takes on superbug in major hospital study
Disease control OngoingThis study aims to compare 28-day mortality among patients with carbapenem resistant A. baumannii infections in two hypothetical target trials where patients receive 7 days of a cefiderocol-based treatment strategy or 7 days of a best available therapy treatment strategy.
Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New hope for frail AML patients: less toxic drug combo shows promise
Disease control CompletedThis study aims to evaluate the efficacy and safety of selinexor-based chemotherapy-sparing regimens (including chemotherapy-free or dose-reduced approaches) in optimizing therapeutic strategies for treatment-naïve acute myeloid leukemia patients deemed unfit for intensive induct…
Phase: NA • Sponsor: Donghua Zhang • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New study explores surgery hope for inoperable pancreatic cancer
Knowledge-focused Recruiting nowPancreatic cancer is a severe disease often diagnosed at an advanced stage, when surgery is not possible. New chemotherapy treatments can sometimes shrink the tumor and make surgery an option. This study aims to understand if surgery after such treatments can improve survival and…
Sponsor: Azienda Ospedaliera di Padova • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
Which diabetes drug protects the heart better? large study aims to find out
Disease control OngoingThis cohort study aims to assess the comparative effectiveness of tirzepatide versus semaglutide with respect to cardiovascular events in patients with type 2 diabetes and heart failure with preserved ejection fraction.
Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Could giving heart drug earlier save more lives?
Disease control Recruiting nowThe primary objective of this pilot, pragmatic stepped-wedge cluster randomized trial is to evaluate if a modified cardiac arrest treatment algorithm calling for the administration of the initial amiodarone dose one 2-minute cycle earlier than current guidelines (during the same …
Phase: PHASE3 • Sponsor: Oregon Health and Science University • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New drug combo aims to outsmart resistant lung cancer
Disease control Recruiting nowOsimertinib combined with savolitinib in the treatment of EGFR mutated osimertinib resistant NSCLC with low copy number MET amplification There are unmet medical needs in patients who resist to to osimertinib; savolitinib plus osimertinib shows high response rate and prolong prog…
Phase: PHASE2 • Sponsor: Qingdao Central Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Stool test could spot stomach cancer before it spreads
Diagnosis OngoingBased on the detection technology of methylation sites in feces, combined or not combined with Helicobacter pylori gastric cancer susceptibility gene detection, an early diagnosis and detection system for gastric cancer is established, and the clinical diagnostic value of the det…
Sponsor: Fudan University • Aim: Diagnosis
Last updated Jun 27, 2026 08:07 UTC
-
New combo therapy aims to shrink unresectable bile duct tumors
Disease control Recruiting nowIntrahepatic cholangiocarcinoma (ICC) has a poor prognosis. The aim of this study is to investigate the efficacy and safety of GP-HAIC combined with immunosuppressants in the treatment of initially unresectable ICC patients, as well as its role in conversion therapy. A prospectiv…
Phase: PHASE2 • Sponsor: Eastern Hepatobiliary Surgery Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Lab-Grown tumors may pick best drug for bladder cancer patients
Disease control Recruiting nowThis study, through a clinical controlled trial, compares the one-year, two-year, and three-year overall survival rates of patients in the treatment group guided by organoid drug sensitivity intervention with those of patients whose medication was based on HER-2 protein expressio…
Sponsor: Qilu Hospital of Shandong University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Mini tumors in a dish could personalize bladder cancer treatment
Knowledge-focused Recruiting nowThis study, through a clinical controlled trial, compared the one-year, three-year, and five-year overall survival rates between patients receiving a treatment plan guided by organoid drug sensitivity and those receiving conventional empirical treatment. Univariate Kaplan-Meier s…
Sponsor: Qilu Hospital of Shandong University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
AI takes on breast cancer screening: a 16,000-Woman trial
Diagnosis Recruiting nowArtificial Intelligence (AI)-assisted imaging technologies (including AI-assisted breast ultrasound and AI-assisted mammography) can effectively improve the accuracy and efficiency of breast imaging examinations, but their application in large-scale population-based breast cancer…
Phase: NA • Sponsor: Fudan University • Aim: Diagnosis
Last updated Jun 27, 2026 09:04 UTC
-
New drug duo aims to slash leukemia relapse after bone marrow transplant
Disease control Recruiting nowThis study aims to determine whether the recurrence rate of high-risk acute myeloid leukemia CR1 patients who received allogeneic hematopoietic stem cell transplantation with the Ruxolitinib, Decitabine combined with Bu/Cy or BuF intensive pretreatment regimen is reduced compared…
Phase: PHASE4 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Engineered immune cells take on tough lymphoma
Disease control Recruiting now1. Study Title: A Study on the Efficacy and safety of CD19/CD20 CAR/TRuC-T in Relapsed/Refractory B-Cell Lymphoma 2. Study Objectives: Primary Objective: To evaluate the safety of CD19/CD20 CAR/TRuC-T cell therapy in patients with relapsed/refractory B-cell lymphoma. …
Phase: PHASE1, PHASE2 • Sponsor: Shenzhen University General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New hope for kids with leukemia in malawi: adapted treatment shows promise
Disease control Recruiting nowIn resource-constrained settings such as Malawi, survival rates for pediatric acute myeloid leukemia (AML) are dismally low compared to high-resource environments. This disparity highlights the urgent need for feasible treatment protocols tailored to the realities of these region…
Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Could a virus injection stop oral cancer before it starts?
Prevention Recruiting nowThe goal of this study is to understand the safety, tolerability, and potential efficacy of an injected immune therapy called RP2 to treat oral precancer conditions and prevent progression to an oral cancer. The name of the study drug involved in this study is: -RP2 (a genetica…
Phase: PHASE2 • Sponsor: Glenn J. Hanna • Aim: Prevention
Last updated Jun 27, 2026 12:23 UTC
-
Could an arthritis drug help the brain heal after a stroke?
Disease control CompletedThis study is an investigator-initiated, prospective, randomized, open-label, blind end-point (PROBE) phase-2 clinical trial, to preliminarily evaluate the efficacy and safety of baritinib for the treatment of acute spontaneous intracerebral hemorrhage (ICH). Approximately 100 pa…
Phase: PHASE2 • Sponsor: De-zhi Kang • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a glaucoma eye drop also heal the cornea?
Disease control CompletedThe goal of this clinical trial is to learn if topical netarsudil/latanoprost works to treat pseudophakic bullous keratopathy in patients with glaucoma. The main questions it aims to answer are: Does topical netarsudil/latanoprost improves visual function in patients with glauco…
Phase: PHASE2, PHASE3 • Sponsor: University Hospital Dubrava • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC